Back to top

genomics: Archive

Moumi Mondal

Illumina's Q3 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?

In the third quarter of 2024, ILMN is likely to have benefited from the significant step-up in consumables with growing customer activity on NovaSeq X.

ILMNPositive Net Change QGENPositive Net Change PACBPositive Net Change

Moumi Mondal

ILMN Stock Trading Near 52-Week High: Should You Buy, Sell or Hold?

Reaching a new one-year high, Illumina remains in investors' sight owing to its strong strategic execution and positive growth outlook.

ILMNPositive Net Change QGENPositive Net Change PACBPositive Net Change